Index of medicine substances

Ponesimod  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants (L04AA50)

Porfimer  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents | Sensitizers used in photodynamic/radiation therapy (L01XD01)

Posaconazole  •  Antiinfectives for systemic use | Antimycotics for systemic use | Antimycotics for systemic use | Triazole derivatives (J02AC04)

Potassium chloride  •  Blood and blood forming organs | I.v. solution additives | Electrolyte solutions (B05XA01)

Potassium citrate + potassium bicarbonate  •  Alimentary tract and metabolism | Potassium (A12BA30)

Potassium iodide  •  Various | All other therapeutic products | All other therapeutic products | Antidotes (V03AB21)

Potassium iodide + sodium iodide  •  Sensory organs | Other ophthalmologicals (S01XA20)

Potassium sodium hydrogen citrate  •  Genito urinary system and sex hormones | Urologicals | Urologicals | Urinary concrement solvents (G04BCN1)

Povidone  •  Sensory organs | Other ophthalmologicals (S01XA20)

Povidone iodine  •  Dermatologicals | Antiseptics and disinfectants | Antiseptics and disinfectants | Iodine products (D08AG02)

Pralsetinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX23)

Pramipexole  •  Nervous system | Dopaminergic agents | Dopamine agonists (N04BC05)

Pramiracetam  •  Nervous system | Psychostimulants, agents used for adhd and nootropics | Other psychostimulants and nootropics (N06BX16)

Pranoprofen  •  Sensory organs | Antiinflammatory agents | Antiinflammatory agents, non-steroids (S01BC09)

Prasterone  •  Genito urinary system and sex hormones | Other sex hormones and modulators of the genital system (G03XX01)

Prasugrel  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Platelet aggregation inhibitors excl. heparin (B01AC22)

Pravastatin  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Hmg coa reductase inhibitors (C10AA03)

Pravastatin + fenofibrate  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, combinations | Combinations of various lipid modifying agents (C10BA03)

Praziquantel  •  Antiparasitic products, insecticides and repellents | Antitrematodals | Quinoline derivatives and related substances (P02BA01)

Prazosin  •  Cardiovascular system | Antiadrenergic agents, peripherally acting | Alpha-adrenoreceptor antagonists (C02CA01)

Pre-pandemic flu vaccine  •  Antiinfectives for systemic use | Viral vaccines | Influenza vaccines (J07BB02)

Prednisolone  •  Sensory organs | Antiinflammatory agents | Corticosteroids, plain (S01BA04)

Prednisolone + neomycin  •  Dermatologicals | Corticosteroids, combinations with antibiotics | Corticosteroids, weak, combinations with antibiotics (D07CA03)

Prednisone  •  Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use | Corticosteroids for systemic use, plain | Glucocorticoids (H02AB07)

Pregabalin  •  Nervous system | Other analgesics and antipyretics | Gabapentinoids (N02BF02)

Pretomanid  •  Antiinfectives for systemic use | Drugs for treatment of tuberculosis | Other drugs for treatment of tuberculosis (J04AK08)

Prilocaine  •  Nervous system | Anesthetics | Anesthetics, local | Amides (N01BB04)

Primaquine  •  Antiparasitic products, insecticides and repellents | Antimalarials | Aminoquinolines (P01BA03)

Primrose root + thyme  •  Respiratory system | Expectorants, excl. combinations with cough suppressants (R05CA10)

Pristinamycin  •  Antiinfectives for systemic use | Macrolides, lincosamides and streptogramins | Streptogramins (J01FG01)